5-HT2 receptors are partially involved in the relationship between renin release and delta relative power

Journal of Endocrinological Investigation

Volumn 19, Issue 8, 1996, Pages 556-562

  Brandenberger, G ^a   Luthringer, R ^b   Muller, G ^b   Gronfier, C ^a   Schaltenbrand, N ^b   Macher, J P ^b   Muzet, A ^a   Follenius, M ^a  

^a Lab Physiol Psychol E   (France)

^b Centre Hospitalier de Rouffach   (France)

Author keywords

5 HT2 receptor; Antagonist sleep; Renin slow wave activity; Ritanserin

Indexed keywords

ANGIOTENSIN I; RENIN; RITANSERIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; HUMAN EXPERIMENT; MALE; NIGHT SLEEP; NONREM SLEEP; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; POLYSOMNOGRAPHY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; RENIN RELEASE; SEROTONINERGIC SYSTEM; SLEEP PATTERN; SLOW WAVE SLEEP; SPECTROSCOPY;

EID: 0029824488     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349016     Document Type: Article

References (31)

1. Hackenthal E., Paul M., Ganten D., Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev. 70: 1067, 1990.
2. Brandenberger G., Follenius M., Goichot B., Saini J., Spiegel K., Ehrhart J., Simon C. Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. J. Hypertens. 12: 277, 1994.
3. Brandenberger G., Follenius M., Simon C., Ehrhart J., Libert J.P. Nocturnal oscillations in plasma renin activity and REM-NREM sleep cycles in humans: a common regulatory mechanism? Sleep 11: 242, 1988.
4. Brandenberger G., Krauth M.O., Ehrhart J., Libert J.P., Simon C., Follenius M. Modulation of episodic renin release during sleep in humans. Hypertension 15: 370, 1990.
5. Follenius M., Krieger J., Krauth M.O., Sforza F., Brandenberger G. Obstructive sleep apnea treatment: peripheral and central etfects of plasma renin activity and aldosterone. Sleep 14: 211 ,1991.
6. Schulz H., Brandenberger G., Gudewill C., Hasse D., Kiss E., Löhr K., Pollmächer T., Follenius M. Plasma renin activity and sleep-wake structure of narcoleptic patients and control subjects under continuous bedrest. Sleep 15: 423, 1992.
7. Brandenberger G., Imbs J.L., Libert J.P., Ehrhart J., Simon C., Santoni J. Ph., Follenius M. Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: The influence of perindopril. J. Endocrinol. Invest. 13: 559, 1990.
8. Jouvet M. Biogenic amines and the states of sleep. Science 163: 32, 1969.
9. Ursin R. The effects of 5-hydroxytryptophan and L-tryptophan on wakeful ness and sleep patterns in the cat. Brain. Res. 106: 105, 1976.
10. Cespuglio R., Houdouin F., Oulerich M., El Mansari M., Jouvet M. Axonal and somato-dendritic modalities of serotonin release: their involvement in sleep preparation, triggering and maintenance. J. Sleep Res. 1: 150, 1992.
11. Sharpley A.L., Solomon R.A., Fernando A.I., da Roza D.J.M., Cowen P.J. Dose-related etfects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 101: 568, 1990.
12. Idzikowski C., Mills F.J., James R.J. A dose-response study examining the effects of ritanserin on human slow wave sleep. Br. J. Clin. Pharmacol. 31: 193, 1991.
13. Dugovic C., Wauquier A. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. Eur. J. Pharmacol. 137:145, 1987.
14. Van de Kar L.D., Wilkinson C.W., Skrobik Y., Brownfield M.S., Ganong W.F. Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone. Brain. Res. 235: 233, 1982.
15. Rittenhouse P.A., Bakkum E.A., Levy A.D., Li Q., Yracheta J., Kunimoto K., Van de Kar L.D. Central Stimulation of renin secretion through serotonergic non cardiovascular mechanisms. Neuroendocrinology 60: 205, 1994.
16. Rittenhouse P.A., Bakkum E.A., Van de Kar L.D., Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. J. Pharmacol. Exp. Ther. 259: 58, 1991.
17. Dugovic C. Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states. J. Sleep Res. 1: 163, 1992.
18. Rechtschaffen A., Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stage of Human Subjects. Washington DC, US Government Printing Office, 1968.
19. Cooley J.W., Tuckey J.W. An algorithm for the machine calculation of complex Fourier series. Math. Comp. 19: 297, 1965.
20. Van Cauter E. Quantitative methods for the analysis of circadian and episodic fluctuations. In: Van Cauter E., Copinschi G. (Eds.), Human pituitary hormones: circadian and episodic variations. Martinus Nijhoff, The Hague, 1981, p. 1.
21. Van de Kar L., Carnes M., Maslowski R.J., Bonadonna A.M., Rittenhouse P.A., Kunimoto K., Piechowski R.A., Bethea C.L. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J. Pharmacol. Exp. Ther. 251: 428, 1989.
22. Idzikowski C., Mills F.J., Glennard R. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res. 378: 164, 1986.
23. Solomon R.A., Sharpley A.L., Cowen P.J. 5-HT antagonists and slow wave sleep. Br. J. Clin. Pharmacol. 25: 125, 1988.
24. Mendlewicz J., Staner L., Kempenaers C., Simmonet M.P., Fransolet L. 5-HT2 receptor antagonism and slow wave sleep in man. In: Paoletti R., Vanhoute P.M., Brunello N., Maggi F.M. (Eds.), Serotonin: from cell biology to pharmacology and therapeutics. Kluwer Academic Publishers, Dordrecht, 1990, p. 523.
25. Adam K., Oswald I. Effects of repeated ritanserin on middle-aged poor sleepers. Psychopharmacology 99: 219, 1989.
26. Lammers G.J., Arends J., Declerck A.C., Kamphuisen H.A.C., Schouwink G., Troost J. Ritanserin, a 5-HT2 receptor blocker, as add -on treatment in narcolepsy. Sleep 14: 130, 1991.
27. Paiva T., Arriaga F., Wauquier A., Lara E., Largo R., Leitao J.N. Effects of ritanserin on sleep disturbances of dysthymic patients. Psychopharmacology 96: 395, 1988.
28. Dugovic C., Wauquier A. 5HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. Eur. J. Pharmacol. 137: 145, 1987.
29. Silhol S., Glin L., Gottesmann C. Study of the 5-HT2 antagonist ritanserin on sleepwaking cycle in the rat. Pharmacol. Biochem. Behav. 41: 241, 1991.
30. Borbely A., Trachsel A., Tobler I. Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur. J. Pharmacol. 156: 275, 1988.
31. Monti J.M., Pineyro G., Orellana C., Boussard M., Jantos H., Labraga P., Olivera S., Alvarino F. 5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane (DOI) and 8-OH-DPAT increase wakefulness in the rat. Bio. Amines 7: 145, 1990.